InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
3
T+90 胜率
0%
T+90 平均收益
-17.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Nussdorf Glenn H, 董事. Director active across 1 company, notably Organogenesis Holdings Inc.. Cumulatively, 6 reports have been published. Split: 2 buys · 3 sells. Total volume traded: €54.5m. History available since 6 May 2021. The latest transaction was disclosed on 16 December 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Nussdorf Glenn H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
200,000 股@ US$5.13531.6% 占其流量Class A Common StockSEC:0002064832-25-000090:0
100,000 股@ US$5.340.9% 占其流量Class A Common StockSEC:0002064832-25-000040:0
251,001 股@ US$3.08781.3% 占其流量Class A Common StockSEC:0002064832-25-000013:0
标准退出：2025年8月12日 (T+90)
25,000 股@ US$9.930.4% 占其流量Class A Common StockSEC:0001062993-21-011406:0
标准退出：2022年2月16日 (T+90)
3,887,500 股@ US$16.4095.9% 占其流量Class A Common StockSEC:0001661181-21-000050:0
23,855,148 股0Class A Common StockSEC:0001661181-21-000040:0
6 条申报中的 6 条
About Nussdorf Glenn H
Glenn H. Nussdorf is a Board Member at Organogenesis Holdings Inc. He plays a key role in the governance and strategy of the company. Nussdorf brings his experience in management and operations to the board. His commitment to efficiency and innovation is essential for the development of Organogenesis.
